PT Phapros, Tbk (PEHA.JK)
- Previous Close
496.00 - Open
496.00 - Bid 494.00 x --
- Ask 496.00 x --
- Day's Range
496.00 - 500.00 - 52 Week Range
484.00 - 1,000.00 - Volume
47,300 - Avg. Volume
621,977 - Market Cap (intraday)
416.64B - Beta (5Y Monthly) 0.39
- PE Ratio (TTM)
70.96 - EPS (TTM)
6.99 - Earnings Date --
- Forward Dividend & Yield 13.37 (2.70%)
- Ex-Dividend Date Jun 19, 2023
- 1y Target Est
--
PT Phapros, Tbk, together with its subsidiaries, operates in the pharmaceutical and health care industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing; and Toll-in Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others. The company also provides generic drug products for government institutions and hospitals, as well as produces drugs for other pharmaceutical industries; and offers medical devices. It exports its products. The company was founded in 1954 and is headquartered in Jakarta, Indonesia. PT Phapros, Tbk is a subsidiary of PT Kimia Farma (Persero) Tbk.
www.phapros.co.id1,474
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: PEHA.JK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PEHA.JK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PEHA.JK
Valuation Measures
Market Cap
416.64B
Enterprise Value
1.15T
Trailing P/E
70.86
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.41
Price/Book (mrq)
0.56
Enterprise Value/Revenue
1.14
Enterprise Value/EBITDA
13.37
Financial Highlights
Profitability and Income Statement
Profit Margin
0.59%
Return on Assets (ttm)
1.87%
Return on Equity (ttm)
0.78%
Revenue (ttm)
1.01T
Net Income Avi to Common (ttm)
5.96B
Diluted EPS (ttm)
6.99
Balance Sheet and Cash Flow
Total Cash (mrq)
65.84B
Total Debt/Equity (mrq)
104.19%
Levered Free Cash Flow (ttm)
-48.23B
Company Insights: PEHA.JK
PEHA.JK does not have Company Insights